Related Experiment Video
Updated: Jan 16, 2026

06:12
Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
Published on: February 12, 2020
7.3K
Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire
Jake F Hooper1, Jarrod M Ellingson1, Kent E Hutchison1
1Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Frontiers in Psychology
|October 1, 2025
Summary
The Psychedelic Aesthetic Experience Questionnaire (PAEQ) effectively measures aesthetic engagement during psychedelic experiences. This validated tool aids in understanding altered states and their therapeutic potential.
Area of Science:
- Psychology
- Psychopharmacology
- Psychometrics
Background:
- Aesthetic experiences under psychedelics are profound but under-measured.
- Existing instruments do not fully capture the aesthetic dimensions of psychedelic states.
- There is a need for a psychometrically sound tool to assess psychedelic-induced aesthetic experiences.
Purpose of the Study:
- To refine and validate the Psychedelic Aesthetic Experience Questionnaire (PAEQ).
- To assess the aesthetic dimensions of acute psychedelic experiences.
- To provide a reliable measure for aesthetic engagement in altered states of consciousness.
Main Methods:
- 365 past-year psilocybin users completed an online survey.
- Exploratory and confirmatory factor analyses (EFA & CFA) examined the PAEQ's structure.
- Reliability, convergent validity, and predictive models for psychological outcomes were evaluated.
Main Results:
- EFA and CFA supported a four-factor structure (sensory, affective, semantic, flow).
- The PAEQ demonstrated high internal consistency (α = 0.90) and convergent validity.
- PAEQ scores predicted modest improvements in sleep, pain, substance use, anxiety, depression, and quality of life.
Conclusions:
- The refined PAEQ is a psychometrically sound instrument for measuring aesthetic engagement during psychedelic experiences.
- The PAEQ's multidimensional structure offers new insights into altered states of consciousness.
- This validated tool advances empirical approaches for characterizing psychedelic experiences and their therapeutic relevance.
Related Concept Videos
Hallucinogens and Psychedelics
607
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
607
Self-Report Tests of Personality
776
Self-report inventories are objective personality assessments that use multiple-choice items or numbered scales, typically ranging from 1 (strongly disagree) to 5 (strongly agree). They are often called Likert scales after Rensis Likert. These inventories are widely used due to their ease of administration and cost-effectiveness. One of the most prominent examples is the Minnesota Multiphasic Personality Inventory (MMPI), initially developed in the 1940s to assess abnormal personality traits.
776
CNS Stimulants: Psychedelic Agents
693
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
693

